Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage I-III lung adenocarcinoma patients.

Xiao-Kai ZhanXi-Kun LiuYonghong FuHong Chen

Published in: Animal models and experimental medicine (2023)

ICOS/ICOSL might be associated with prognosis of lung cancer, and ICOS and its ligand may be potential therapeutic targets in non-small cell lung cancer.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
poor prognosis
patient reported outcomes
climate change